The European Medicines Agency on Wednesday said that the benefits of the vaccine made by Johnson & Johsnson in preventing COVID-19 outweigh the risks of side effects, said the Amsterdam-based European Union medicines regulator said on Wednesday. ...
The European Medicines Agency (EMA) on Wednesday acknowledged a "possible link" between the AstraZeneca vaccine and "very rare cases of blood clots" but said the benefits of the vaccine, however, continue to outweigh the risks. ...
The UK government's joint committee on vaccination recommended on Wednesday that people under 30 be offered an alternative to AstraZeneca amid concerns that the anti-coronavirus vaccine may cause rare blood clots in younger people. ...
Finland on Friday suspended the use of Oxford-AstraZeneca COVID-19 vaccines after two cases of blood clots were reported in people after receiving the dose. ...
Finland on Friday suspended the use of Oxford-AstraZeneca COVID-19 vaccines after two cases of blood clots were reported in people after receiving the dose. ...
